To assess whether there is an additive effect between chronic hepatitis B virus (HBV) and
hepatitis C virus (HCV) infection on the development of hepatocellular carcinoma (HCC) …

Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer death, with few
treatment options for advanced disease. Objectives: Here, we review the aetiology of HCC …

Patients with chronic viral hepatitis and cirrhosis often have elevated serum (X-fetoprotein
(AFP) values, the causes of which are unclear. We studied 81 patients with chronic hepatitis …

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and is often
diagnosed at an advanced stage. We have investigated α-fetoprotein (AFP) as a tumor …

Although alpha‐fetoprotein (AFP) is a widely used tumor marker in hepatocellular carcinoma
(HCC), 40% of newly diagnosed patients do not have an elevated AFP level. Research has …

Aims: To investigate the incidence of ordering tests for tumor markers which are used in
cancer diagnosis, follow-up treatment and detection of recurrence, the rate of elevation in …

Three cases of extreme elevation of serum alpha fetoprotein (> 10,000 ng/mL) with
decompensated cirrhosis without demonstrable hepatocellular carcinoma are reported …

The incidence of hepatocellular carcinoma (HCC) is increasing worldwide, with the second
highest increase in overall death rates. The mobidity and mortality of HCC are virtually …

Hepatitis B is a global health problem, affecting> 2 billion people worldwide. Chronicity
develops in> 90% of neonates infected by hepatitis B virus (HBV). After several decades of …

Hepatitis B is a global health problem, affecting> 2 billion people worldwide. Chronicity
develops in> 90% of neonates infected by hepatitis B virus (HBV). After several decades of …